{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Corticosteroids and Contrast for Pain Procedures: Anesthesia Board Prep Pearls!","description":" \ud83c\udf99\ufe0f PainExam Podcast Show Notes  Corticosteroids &amp;amp; Contrast Agents in Pain Management + Evidence-Based Steroid Selection  \ud83d\udd25 Episode Overview In this high-yield episode of the PainExam Podcast, David Rosenblum breaks down a must-know board topic: \ud83d\udc49 Injectable corticosteroids vs contrast agents in interventional pain procedures This episode goes beyond basics and dives into:   Particulate vs non-particulate steroids  Comparative profiles of dexamethasone, betamethasone, triamcinolone, and methylprednisolone  Contrast agent selection and safety  Critical complications including embolization and neurotoxicity A recent study comparing steroid effectiveness in transforaminal epidural injections  This is essential for physicians preparing for the ABA Pain Medicine boards and for clinicians performing spine interventions.  \ud83e\udde0 Core Concept   Corticosteroids = therapeutic (reduce inflammation)  Contrast agents = diagnostic + safety tools (confirm needle placement)  \ud83d\udc49 Board pearl: Steroids treat pain \u2014 contrast prevents complications  \ud83d\udc89 Corticosteroids \u2014 High-Yield Comparison \ud83d\udd2c Mechanism   Inhibit phospholipase A2  Reduce inflammatory mediators  Decrease nerve root irritation   \u2696\ufe0f Key Steroids Compared       Steroid  Type  Particle Profile  Key Advantage  Major Risk      Dexamethasone  Non-particulate No aggregation Safest for TFESI Possibly shorter duration    Triamcinolone  Particulate Large particles Longer depot effect Embolic infarction    Methylprednisolone  Particulate  Aggregates Strong anti-inflammatory Avoid in cervical TFESI    Betamethasone Mixed Depends on formulation  Potent Acetate = particulate risk       \ud83d\udea8 Major Steroid Risks Local:   Tissue atrophy  Depigmentation  Systemic:   Hyperglycemia  Adrenal suppression  Immunosuppression  Catastrophic (Board Tested):   Spinal cord infarction  Stroke  \ud83d\udc49 Caused by intra-arterial injection of particulate steroids  \ud83d\udcca Contrast Agents \u2014 High-Yield Review  Common Agents   Iohexol (Omnipaque)  Iopamidol (Isovue)  Iodixanol (Visipaque)   \ud83c\udfaf Purpose   Confirm needle placement  Detect intravascular injection  Prevent intrathecal injection   \u26a0\ufe0f Risks   Allergic reaction  Anaphylaxis  Contrast-induced nephropathy  \ud83d\udc49 Board pearl: Shellfish allergy \u2260 contrast allergy  \u26a0\ufe0f Critical Safety Topic: Gadolinium Gadolinium-based contrast agents are: \u274c NOT approved for epidural or intrathecal use \u274c NOT safe substitutes for iodinated contrast in spine procedures  \ud83d\udea8 Intrathecal Gadolinium Risks   Encephalopathy  Seizures  Respiratory distress  Death  \ud83d\udc49 Extremely high-yield board concept  \ud83d\udcda Evidence-Based Medicine Segment  Study Review: Steroid Selection in TFESI A recent study comparing:   Dexamethasone  Methylprednisolone  Betamethasone   \ud83d\udd11 Key Findings   Dexamethasone showed comparable or better outcomes No clear advantage of particulate steroids  Similar rates of:   Repeat injections  Surgical progression     \ud83c\udfaf Clinical Implication \ud83d\udc49 Efficacy differences are smaller than previously thought \ud83d\udc49 Safety is driving practice change  \ud83d\udea8 Board-Level Takeaway   Non-particulate steroids = safer  Outcomes \u2248 similar  Technique matters more than steroid choice  \ud83d\udc49 Best exam answer: dexamethasone for TFESI  \ud83c\udfaf Board Prep Summary   Dexamethasone = safest for transforaminal injections  Particulate steroids = embolic risk  Contrast must be used before steroid injection  Gadolinium = dangerous in neuraxial space  Clinical outcomes often similar across steroid types   \ud83c\udf93 Pain Board Prep Resources Prepare for your ABA Pain Medicine boards with: \ud83d\udc49 https:\/\/painexam.com \ud83d\udc49 https:\/\/nrappain.org  \ud83c\udfc6 Why Physicians Choose NRAP Academy   High-yield board review content  Thousands of MCQs  Virtual Pain Fellowship  Ultrasound + regenerative training  Real-world clinical integration  Register Today!  \ud83c\udfa4 Upcoming Training   Ultrasound-guided pain procedures  Regenerative medicine courses (PRP, biologics)  Hands-on workshops  Register Today!  \ud83d\udce2 Call to Action If you\u2019re serious about passing your boards and practicing safer interventional pain medicine: \u2705 Subscribe to the PainExam Podcast \u2705 Join the Virtual Pain Fellowship \u2705 Visit https:\/\/nrappain.org &amp;nbsp; References Calvo N, Jamil M, Feldman S, Shah A, Nauman F, Ferrara J. Neurotoxicity from intrathecal gadolinium administration: Case presentation and brief review. Neurol Clin Pract. 2020 Feb;10(1):e7-e10. doi: 10.1212\/CPJ.0000000000000696. PMID: 32190427; PMCID: PMC7057078. Moreira, Alexandra M., et al. &quot;Comparing the effectiveness and safety of dexamethasone, methylprednisolone and betamethasone in lumbar transforaminal epidural steroid injections.&quot; Pain physician 27.5 (2024): 341. ","author_name":"AnesthesiaExam Podcast","author_url":"http:\/\/anesthesiaexampodcast.libsyn.com\/podcast","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41061040\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/201448270"}